A Study of WD-890 in Participants With Moderate-to-Severe Plaque Psoriasis

Clinical trial NCT06912165 · RECRUITING

Trial details

NCT number: NCT06912165
Sponsor: Zhejiang Wenda Pharma Technology LTD.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Brief Description of Focus of Study

Start date: 2024-12-31
Primary completion: 2025-10-30
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.